Compare $BOLT vs $MBRX | Chartloom

Compare

$BOLT vs $MBRX

Bolt Biotherapeutics Inc · Moleculin Biotech Inc

BOLT

Bolt Biotherapeutics Inc

MBRX

Moleculin Biotech Inc

Compare $BOLT vs $MBRX

Comparing Bolt Biotherapeutics Inc and Moleculin Biotech Inc

BOLTBolt Biotherapeutics Inc

MBRXMoleculin Biotech Inc

BOLTBolt Biotherapeutics Inc

Market cap

$8M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

12.8%

YTD performance

-29.0%

52W performance

-35.8%

FCF yield

-399.6%

MBRXMoleculin Biotech Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-87.8%

52W performance

-96.5%

FCF yield

-811.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BOLT

MBRX

Detailed metrics comparison

BOLT

Bolt Biotherapeutics Inc

MBRX

Moleculin Biotech Inc

Market Cap

BOLT$8M

MBRX$3M

Enterprise Value

BOLT$-5M

MBRX$-4M

Price

BOLT$4.11

MBRX$0.44

P/E Ratio

BOLTN/A

MBRXN/A

P/S Ratio

BOLT1.68x

MBRX0.00x

EV/Sales

BOLT-1.06x

MBRX0.00x

EV/EBITDA

BOLT0.00x

MBRX0.00x

P/B Ratio

BOLT0.53x

MBRX0.86x

P/FCF Ratio

BOLTN/A

MBRXN/A

EV/FCF

BOLT0.16x

MBRX0.16x

PEG Ratio

BOLTN/A

MBRXN/A

Forward P/E (NTM)

BOLTN/A

MBRXN/A

Forward P/S (NTM)

BOLTN/A

MBRXN/A

Revenue (TTM)

BOLT$5M

MBRX$0

Revenue Growth (YoY)

BOLT12.8%

MBRXN/A

Forward Rev Growth

BOLT1650.0%

MBRX131.1%

Gross Margin (TTM)

BOLT0.0%

MBRX0.0%

Operating Margin (TTM)

BOLT0.0%

MBRX0.0%

EBITDA Margin (TTM)

BOLT-586.3%

MBRX0.0%

Net Margin (TTM)

BOLT-611.5%

MBRX0.0%

FCF Margin (TTM)

BOLT-671.0%

MBRXN/A

Net Income (TTM)

BOLT$-29M

MBRX$-33M

FCF (TTM)

BOLT$-32M

MBRX$-25M

EPS (TTM)

BOLT-$17.00

MBRX-$5.73

ROE (TTM)

BOLT-12623.0%

MBRX-3539.0%

ROA (TTM)

BOLT-5470.0%

MBRX-13955.0%

ROIC (TTM)

BOLT-12623.0%

MBRX-3539.0%

Cash

BOLT$13M

MBRX$7M

Debt

BOLT$0

MBRX$0

Net Cash/Debt

BOLT$13M

MBRX$7M

Current Ratio (TTM)

BOLT2.61x

MBRX0.94x

Quick Ratio (TTM)

BOLT2.26x

MBRX0.78x

Debt/Equity (TTM)

BOLT0.00x

MBRX0.00x

Debt/Assets (TTM)

BOLT0.0%

MBRX0.0%

Interest Coverage (TTM)

BOLTN/A

MBRXN/A

Net Debt/EBITDA (TTM)

BOLT0.00x

MBRX0.00x

Beta

BOLT0.97

MBRX2.10

52W Performance

BOLT-35.8%

MBRX-96.5%

YTD Performance

BOLT-29.0%

MBRX-87.8%

% from 52W High

BOLT-42.9%

MBRX-97.2%

% from 52W Low

BOLT32.6%

MBRX173.9%

Asset Turnover (TTM)

BOLT0.09x

MBRX0.00x

FCF Yield (TTM)

BOLT-399.6%

MBRX-811.4%

Earnings Yield (TTM)

BOLT-364.2%

MBRX-1040.8%

Dividend Yield (TTM)

BOLTN/A

MBRXN/A

Rule of 40

BOLT-658.2

MBRX0.0

EV/GP/RG

BOLTN/A

MBRXN/A

Ticker research

View BOLT research View MBRX research

Metric	BOLT Bolt Biotherapeutics Inc	MBRX Moleculin Biotech Inc
Market & Valuation
Market Cap	$8M	$3M
Enterprise Value	$-5M	$-4M
Price	$4.11	$0.44
P/E Ratio	N/A	N/A
P/S Ratio	1.68x	0.00x
EV/Sales	-1.06x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.53x	0.86x
P/FCF Ratio	N/A	N/A
EV/FCF	0.16x	0.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$5M	$0
Revenue Growth (YoY)	12.8%	N/A
Forward Rev Growth	1650.0%	131.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-586.3%	0.0%
Net Margin (TTM)	-611.5%	0.0%
FCF Margin (TTM)	-671.0%	N/A
Net Income (TTM)	$-29M	$-33M
FCF (TTM)	$-32M	$-25M
EPS (TTM)	-$17.00	-$5.73
ROE (TTM)	-12623.0%	-3539.0%
ROA (TTM)	-5470.0%	-13955.0%
ROIC (TTM)	-12623.0%	-3539.0%
Financial Health
Cash	$13M	$7M
Debt	$0	$0
Net Cash/Debt	$13M	$7M
Current Ratio (TTM)	2.61x	0.94x
Quick Ratio (TTM)	2.26x	0.78x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.97	2.10
52W Performance	-35.8%	-96.5%
YTD Performance	-29.0%	-87.8%
% from 52W High	-42.9%	-97.2%
% from 52W Low	32.6%	173.9%
Efficiency & Yields
Asset Turnover (TTM)	0.09x	0.00x
FCF Yield (TTM)	-399.6%	-811.4%
Earnings Yield (TTM)	-364.2%	-1040.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-658.2	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BOLT research	View MBRX research

Valuation

P/S Ratio

MBRX

0.00x

BOLT

1.68x

EV/FCF

BOLT

0.16x

MBRX

0.16x

Growth & revenue

Revenue Growth TTM

BOLT

12.8%

Forward Revenue Growth

BOLT

1650.0%

MBRX

131.1%

Profitability & performance

Gross Margin

BOLT

0.0%

MBRX

0.0%

ROE

MBRX

-3539.0%

BOLT

-12623.0%

FCF Yield %

BOLT

-399.6%

MBRX

-811.4%

52-Week Performance

BOLT

-35.8%

MBRX

-96.5%

Detailed metrics comparison

BOLT

Bolt Biotherapeutics Inc

MBRX

Moleculin Biotech Inc

Market Cap

BOLT$8M

MBRX$3M

Enterprise Value

BOLT$-5M

MBRX$-4M

Price

BOLT$4.11

MBRX$0.44

P/E Ratio

BOLTN/A

MBRXN/A

P/S Ratio

BOLT1.68x

MBRX0.00x

EV/Sales

BOLT-1.06x

MBRX0.00x

EV/EBITDA

BOLT0.00x

MBRX0.00x

P/B Ratio

BOLT0.53x

MBRX0.86x

P/FCF Ratio

BOLTN/A

MBRXN/A

EV/FCF

BOLT0.16x

MBRX0.16x

PEG Ratio

BOLTN/A

MBRXN/A

Forward P/E (NTM)

BOLTN/A

MBRXN/A

Forward P/S (NTM)

BOLTN/A

MBRXN/A

Revenue (TTM)

BOLT$5M

MBRX$0

Revenue Growth (YoY)

BOLT12.8%

MBRXN/A

Forward Rev Growth

BOLT1650.0%

MBRX131.1%

Gross Margin (TTM)

BOLT0.0%

MBRX0.0%

Operating Margin (TTM)

BOLT0.0%

MBRX0.0%

EBITDA Margin (TTM)

BOLT-586.3%

MBRX0.0%

Net Margin (TTM)

BOLT-611.5%

MBRX0.0%

FCF Margin (TTM)

BOLT-671.0%

MBRXN/A

Net Income (TTM)

BOLT$-29M

MBRX$-33M

FCF (TTM)

BOLT$-32M

MBRX$-25M

EPS (TTM)

BOLT-$17.00

MBRX-$5.73

ROE (TTM)

BOLT-12623.0%

MBRX-3539.0%

ROA (TTM)

BOLT-5470.0%

MBRX-13955.0%

ROIC (TTM)

BOLT-12623.0%

MBRX-3539.0%

Cash

BOLT$13M

MBRX$7M

Debt

BOLT$0

MBRX$0

Net Cash/Debt

BOLT$13M

MBRX$7M

Current Ratio (TTM)

BOLT2.61x

MBRX0.94x

Quick Ratio (TTM)

BOLT2.26x

MBRX0.78x

Debt/Equity (TTM)

BOLT0.00x

MBRX0.00x

Debt/Assets (TTM)

BOLT0.0%

MBRX0.0%

Interest Coverage (TTM)

BOLTN/A

MBRXN/A

Net Debt/EBITDA (TTM)

BOLT0.00x

MBRX0.00x

Beta

BOLT0.97

MBRX2.10

52W Performance

BOLT-35.8%

MBRX-96.5%

YTD Performance

BOLT-29.0%

MBRX-87.8%

% from 52W High

BOLT-42.9%

MBRX-97.2%

% from 52W Low

BOLT32.6%

MBRX173.9%

Asset Turnover (TTM)

BOLT0.09x

MBRX0.00x

FCF Yield (TTM)

BOLT-399.6%

MBRX-811.4%

Earnings Yield (TTM)

BOLT-364.2%

MBRX-1040.8%

Dividend Yield (TTM)

BOLTN/A

MBRXN/A

Rule of 40

BOLT-658.2

MBRX0.0

EV/GP/RG

BOLTN/A

MBRXN/A

Ticker research

View BOLT research View MBRX research

Metric	BOLT Bolt Biotherapeutics Inc	MBRX Moleculin Biotech Inc
Market & Valuation
Market Cap	$8M	$3M
Enterprise Value	$-5M	$-4M
Price	$4.11	$0.44
P/E Ratio	N/A	N/A
P/S Ratio	1.68x	0.00x
EV/Sales	-1.06x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.53x	0.86x
P/FCF Ratio	N/A	N/A
EV/FCF	0.16x	0.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$5M	$0
Revenue Growth (YoY)	12.8%	N/A
Forward Rev Growth	1650.0%	131.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-586.3%	0.0%
Net Margin (TTM)	-611.5%	0.0%
FCF Margin (TTM)	-671.0%	N/A
Net Income (TTM)	$-29M	$-33M
FCF (TTM)	$-32M	$-25M
EPS (TTM)	-$17.00	-$5.73
ROE (TTM)	-12623.0%	-3539.0%
ROA (TTM)	-5470.0%	-13955.0%
ROIC (TTM)	-12623.0%	-3539.0%
Financial Health
Cash	$13M	$7M
Debt	$0	$0
Net Cash/Debt	$13M	$7M
Current Ratio (TTM)	2.61x	0.94x
Quick Ratio (TTM)	2.26x	0.78x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.97	2.10
52W Performance	-35.8%	-96.5%
YTD Performance	-29.0%	-87.8%
% from 52W High	-42.9%	-97.2%
% from 52W Low	32.6%	173.9%
Efficiency & Yields
Asset Turnover (TTM)	0.09x	0.00x
FCF Yield (TTM)	-399.6%	-811.4%
Earnings Yield (TTM)	-364.2%	-1040.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-658.2	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BOLT research	View MBRX research